20 mM Tris, pH 7.5.
Reconstitute in water to a concentration of 0.1-1.0 mg/ml. This solution can then be diluted into other aqueous buffers and stored at 4ºC for 1 week or –20ºfor future use.
Purity was assessed by SDS-PAGE (≥98%) and by HPLC.
For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Galectin1, beta-galactoside- binding lectin L-14-I, SLac lectin1, Lectin galactosidebinding soluble1, betagalactoside binding lectin L14I, Lectin galactosidebinding soluble 1, Putative MAPK-activating protein PM12, LGALS1, L, S-Lac lectin 1, Galaptin, DKFZp686E23103, Putative MAPKactivating protein PM12, S Lac lectin 1, SLac lectin 1
Galectin-1 belongs to growing family of evolutionary conserved animal lectins. Galectins consists of beta-galactoside binding lectins that contain homologous carbohydrate recognition domains (CRDs). Galectin-1 has the ability to induce apoptosis of activated T-cells and T-leukaemia cell lines. Other activities include cell differentiation and inhibition activity of CD45 protein phosphatase activity. Galectin also binds beta-galactoside as well as CD45, CD3 and CD4. Recombinant Human Galectin is a 14.5 kDa protein consisting of 134 amino acid residues.